Racial Disparities in the Quality of Medication Use in Older Adults: Baseline Findings from a Longitudinal Study

Overview

Journal J Gen Intern Med

Publisher Springer

Specialty General Medicine

Date 2009 Dec 17

PMID 20012561

Citations 10

Authors

Mary T Roth

Denise A Esserman

Jena L Ivey

Morris Weinberger

Affiliations

Soon will be listed here.

Abstract

Background: Medication-related problems are prevalent in older adults and adversely affect the quality of care. It has been suggested that racial differences exist in medication use. Most efforts to evaluate the quality of medication use target specific drugs or disease states, or a set of pre-defined quality indicators, rather than the patient.

Objective: We conducted a prospective cohort study to determine the prevalence and types of medication-related problems in older adults, examining the impact of race on quality medication use.

Methods: In-home interviews and medical record reviews of 200 (100 white, 100 black) older adults were conducted three times over 1 year. The quality of medication use was measured using a clinical pharmacist's assessment of quality and the Assessing Care of Vulnerable Elders quality indicators. We used logistic and negative binomial regression models to analyze the two primary endpoints of prevalence and number of medication-related problems.

Results: Mean age was 78.3 (whites) and 75.5 (blacks), with the majority being female. Although whites used more medications than blacks (11.6 versus 9.7; p < 0.01), blacks had more medication-related problems per person than whites (6.2 versus 4.9; p < 0.01). All patients had at least one medication-related problem; undertreatment, suboptimal drug, suboptimal dosing, and nonadherence were most prevalent. Blacks had significantly higher rates of nonadherence than whites (68% versus 42%; p < 0.01).

Conclusion: Medication-related problems are prevalent in community-residing older adults. Blacks had more medication-related problems than whites, including higher rates of nonadherence. These findings require further study to better understand racial disparities in quality medication use.

Citing Articles

Pharmacoequity measurement framework: A tool to reduce health disparities.

Patel P, Essien U, Happe L J Manag Care Spec Pharm. 2025; 31(2):214-224.

PMID: 39912813 PMC: 11801364. DOI: 10.18553/jmcp.2025.31.2.214.

Associations between sex, race/ethnicity, and age and the initiation of chronic high-risk medication in US older adults.

Jungo K, Choudhry N, Chaitoff A, Lauffenburger J J Am Geriatr Soc. 2024; 72(12):3705-3718.

PMID: 39215549 PMC: 11637294. DOI: 10.1111/jgs.19173.

The association between socioeconomic status and use of potentially inappropriate medications in older adults.

Hwang J, Lyu B, Ballew S, Coresh J, Grams M, Couper D J Am Geriatr Soc. 2022; 71(4):1156-1166.

PMID: 36511705 PMC: 10089965. DOI: 10.1111/jgs.18165.

Risk factors for drug therapy problems among Cambodian Americans with complex needs: a cross-sectional, observational study.

Wagner J, Bermudez-Millan A, Berthold S, Buckley T, Buxton O, Feinn R Health Psychol Behav Med. 2022; 10(1):145-159.

PMID: 35087696 PMC: 8788352. DOI: 10.1080/21642850.2021.2021917.

Promoting MedlinePlus utilization in a federally qualified health center using a multimodal approach.

Sanders M, Bringley K, Thomas M, Boyd M, Farah S, Fiscella K J Med Libr Assoc. 2018; 106(3):361-369.

PMID: 29962914 PMC: 6013131. DOI: 10.5195/jmla.2018.216.

References

Hohl C, Dankoff J, Colacone A, Afilalo M . Polypharmacy, adverse drug-related events, and potential adverse drug interactions in elderly patients presenting to an emergency department. Ann Emerg Med. 2001; 38(6):666-71. DOI: 10.1067/mem.2001.119456. View

Roth M, Moore C, Ivey J, Esserman D, Campbell W, Weinberger M . The quality of medication use in older adults: methods of a longitudinal study. Am J Geriatr Pharmacother. 2008; 6(4):220-33. PMC: 2672424. DOI: 10.1016/j.amjopharm.2008.10.004. View

Kerr E, Smith D, Hogan M, Hofer T, Krein S, Bermann M . Building a better quality measure: are some patients with 'poor quality' actually getting good care?. Med Care. 2003; 41(10):1173-82. DOI: 10.1097/01.MLR.0000088453.57269.29. View

Hanlon J, Weinberger M, Samsa G, Schmader K, Uttech K, Lewis I . A randomized, controlled trial of a clinical pharmacist intervention to improve inappropriate prescribing in elderly outpatients with polypharmacy. Am J Med. 1996; 100(4):428-37. DOI: 10.1016/S0002-9343(97)89519-8. View

Ernst F, Grizzle A . Drug-related morbidity and mortality: updating the cost-of-illness model. J Am Pharm Assoc (Wash). 2001; 41(2):192-9. DOI: 10.1016/s1086-5802(16)31229-3. View

Shrank W, Polinski J, Avorn J . Quality indicators for medication use in vulnerable elders. J Am Geriatr Soc. 2007; 55 Suppl 2:S373-82. DOI: 10.1111/j.1532-5415.2007.01345.x. View

Higashi T, Shekelle P, Adams J, Kamberg C, Roth C, Solomon D . Quality of care is associated with survival in vulnerable older patients. Ann Intern Med. 2005; 143(4):274-81. DOI: 10.7326/0003-4819-143-4-200508160-00008. View

Kassam R, Farris K, Burback L, Volume C, Cox C, Cave A . Pharmaceutical care research and education project: pharmacists' interventions. J Am Pharm Assoc (Wash). 2001; 41(3):401-10. DOI: 10.1016/s1086-5802(16)31254-2. View

Saha S, Freeman M, Toure J, Tippens K, Weeks C, Ibrahim S . Racial and ethnic disparities in the VA health care system: a systematic review. J Gen Intern Med. 2008; 23(5):654-71. PMC: 2324157. DOI: 10.1007/s11606-008-0521-4. View

10.

Callahan C, Unverzagt F, Hui S, Perkins A, Hendrie H . Six-item screener to identify cognitive impairment among potential subjects for clinical research. Med Care. 2002; 40(9):771-81. DOI: 10.1097/00005650-200209000-00007. View

11.

Chassin M . Quality of care. Time to act. JAMA. 1991; 266(24):3472-3. View

12.

Murray M, Young J, Hoke S, Tu W, Weiner M, Morrow D . Pharmacist intervention to improve medication adherence in heart failure: a randomized trial. Ann Intern Med. 2007; 146(10):714-25. DOI: 10.7326/0003-4819-146-10-200705150-00005. View

13.

Fillenbaum G, Hanlon J . Racial and ethnic disparities in medication use among older adults. Am J Geriatr Pharmacother. 2006; 4(2):93-5. DOI: 10.1016/j.amjopharm.2006.06.005. View

14.

Lawton M, Brody E . Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969; 9(3):179-86. View

15.

Johnson J, Bootman J . Drug-related morbidity and mortality. A cost-of-illness model. Arch Intern Med. 1995; 155(18):1949-56. View

16.

Baker D, Williams M, Parker R, Gazmararian J, Nurss J . Development of a brief test to measure functional health literacy. Patient Educ Couns. 2003; 38(1):33-42. DOI: 10.1016/s0738-3991(98)00116-5. View

17.

Ostrom J, HAMMARLUND E, Christensen D, PLEIN J, Kethley A . Medication usage in an elderly population. Med Care. 1985; 23(2):157-64. DOI: 10.1097/00005650-198502000-00006. View

18.

Fick D, Cooper J, Wade W, Waller J, Maclean J, Beers M . Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003; 163(22):2716-24. DOI: 10.1001/archinte.163.22.2716. View

19.

Strand L, Morley P, Cipolle R, Ramsey R, Lamsam G . Drug-related problems: their structure and function. DICP. 1990; 24(11):1093-7. DOI: 10.1177/106002809002401114. View

20.

Gaskin D, Briesacher B, Limcangco R, Brigantti B . Exploring racial and ethnic disparities in prescription drug spending and use among Medicare beneficiaries. Am J Geriatr Pharmacother. 2006; 4(2):96-111. DOI: 10.1016/j.amjopharm.2006.06.008. View